Search company, investor...

Predict your next investment

SpringTide company logo
Venture Capital
springtideinvestments.com

Investments

13

Portfolio Exits

1

Funds

1

About SpringTide

SpringTide offers a venture health fund that aims to help and invest in healthcare AI companies.

Headquarters Location

Cambridge, Massachusetts, 02141,

United States

801-822-2544

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Latest SpringTide News

Mawson and Springtide Provide Update on the Springtide Transaction and Financing

Nov 16, 2023

Mawson and Springtide Provide Update on the Springtide Transaction and Financing Ansprechpartner:in Herr Jochen Staiger +41 71 354 85 01 ) NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. Mawson Gold Limited (“Mawson” or the “Company”- https://www.commodity-tv.com/ondemand/companies/profil/mawson-gold-ltd/ ) (TSX: MAW) (Frankfurt: MXR) (PINKSHEETS: MWSNF) and Springtide Capital Acquisitions 7 Inc. (“Springtide”) are pleased to provide an update on the transaction (the “Springtide Transaction”) pursuant to which Springtide will acquire the Company’s Rajapalot gold-cobalt project in Finland (“Rajapalot”), previously disclosed in the Company’s news release of October 31, 2023. Pursuant to the Springtide Transaction, Springtide will undertake a non-brokered best efforts private placement financing of a minimum of 14,745,541 special warrants of Springtide (“Special Warrants”) at a price of CAD$1.00 per Special Warrant for minimum gross proceeds of CAD$14,745,541 (the “Non-Brokered Special Warrant Financing”). The Special Warrants will be initially offered to Mawson shareholders who are  ”accredited investors” (as such term is defined under applicable Canadian securities law) on the basis of one (1) Special Warrant offered per twenty (20) common shares of Mawson held (the “Allocation”), and then offered to any other additional parties, as Mawson and Springtide may agree, in each of the provinces of Canada, other than Québec, and any other jurisdictions as the parties may agree. Each Special Warrant will be exercisable into one (1) common share in the capital of Springtide (each a “Springtide Share”) at any time at the option of the holder thereof (the “Special Warrantholder”) and will be deemed to be exercised (without any further action or additional consideration on the part of the Special Warrantholders) at 5:00 p.m. (Toronto time) on the earlier of: (i) the date of a go public event (a “Go Public Event”), pursuant to which Springtide will  become a reporting issuer and the Springtide Shares will be listed and posted for trading on a stock exchange in Canada or the United States; or (ii) the second anniversary of the closing of the Transaction Financing. Springtide shall use its reasonable best efforts to complete a Go Public Event on the TSX Venture Exchange on or before March 31, 2024. The gross proceeds of the Non-Brokered Special Warrant Financing will be returned to the subscribers if the Springtide Transaction does not receive approval of the Mawson shareholders or regulatory approval. Shareholders who do not qualify as “accredited investors” will have the opportunity to participate in a future brokered private placement financing (the “Brokered Offering”, and together with the Non-Brokered Special Warrant Financing, the “Transaction Financings”) on the same terms as the Non-Brokered Special Warrant Financing  concurrently with  Springtide’s completion of a Go Public Event  It is anticipated that Springtide will engage an agent for the Brokered Offering and that agent’s fees will be paid by Springtide on the Brokered Offering. The closing of the Non-Brokered Special Warrant Financing is expected to occur on or about December 18, 2023, while closing of the Brokered Offering is expected to occur concurrently with Springtide’s Go Public Event. Shareholders who wish to participate in the Non-Brokered Special Warrant Financing or the Brokered Offering, as applicable, are encouraged to contact Mr. Neil MacRae, Director of Mawson, at 1.778.999.4653 or info@mawsongold.com with evidence of their shareholdings in the Company  as soon as possible and in any event by no later than 72 hours prior to the closing of each of the Non-Brokered Special Warrant Financing or Brokered Offering, as applicable. CAD$6,500,000 of the proceeds of the Transaction Financings will be used by Springtide to pay the purchase price of the Springtide Transaction, and the balance of approximately CAD$8,500,000 will be used to fund resource expansion at Rajapalot, Finland, and for general working capital. The Springtide Shares underlying the Special Warrants pursuant to the Non-Brokered Special Warrant Financing will be subject to a four month hold period from the later of the closing date and the date on which Springtide becomes a reporting issuer in any jurisdiction of Canada, until completion of the Go Public Event, whereupon the Springtide Shares will no longer be subject to resale restrictions in Canada. Springtide will qualify the Springtide Shares underlying the Special Warrants and issued pursuant to the Brokered Offering under a prospectus to be filed in connection with the Go Public Event. For further information on the Springtide Transaction, please see the Company’s news release dated October 31, 2023. The Springtide Transaction is subject to regulatory and Mawson shareholder approval. Shareholder Questions Shareholders who have additional questions about the proposed transactions or need more information, may contact the Company’s shareholder communications advisor and proxy solicitation agent, Laurel Hill Advisory Group, by telephone at 1 (877) 452 7184 toll-free in Canada or 1 (416) 304 0211 for international calls or by e-mail at assistance@laurelhill.com About Mawson Gold Limited Mawson Gold Limited has distinguished itself as a leading Nordic exploration company. Over the last decades, the team behind Mawson has forged a long and successful record of discovering, financing, and advancing mineral projects in the Nordics and Australia, including the Rajapalot Au-Co PEA-stage project in Finland, the Skelleftea Au discovery and a portfolio of historic uranium resources in Sweden. Mawson also currently holds 51% of Southern Cross Gold Ltd. (ASX:SXG) which owns or controls three high-grade, historic epizonal goldfields covering 470 km2 in Victoria, Australia, including the Sunday Creek Au-Sb asset. About Springtide Springtide Capital Acquisitions 7 Inc. is a newly incorporated arm’s length entity existing under the laws of Ontario with minimal share capital owned by Mr. Darren Morcombe, who is an existing Shareholder holding less than 8% of the issued and outstanding common shares of Mawson. Springtide was established for the purpose of completing the Springtide Transaction and currently has no assets or liabilities. On behalf of the Board of Mawson Gold Limited "Michael Hudson"

SpringTide Investments

13 Investments

SpringTide has made 13 investments. Their latest investment was in Pathology Watch as part of their Series C on March 3, 2023.

CBI Logo

SpringTide Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/8/2023

Series C

Pathology Watch

$22.34M

No

1

7/26/2022

Series A

RxLive

$5M

Yes

2

7/6/2022

Unattributed VC - III

Paloma Health

$2.66M

Yes

1

2/1/2022

Seed VC - III

Subscribe to see more

$99M

Subscribe to see more

10

12/13/2021

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/8/2023

7/26/2022

7/6/2022

2/1/2022

12/13/2021

Round

Series C

Series A

Unattributed VC - III

Seed VC - III

Series A

Company

Pathology Watch

RxLive

Paloma Health

Subscribe to see more

Subscribe to see more

Amount

$22.34M

$5M

$2.66M

$99M

$99M

New?

No

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

2

1

10

10

SpringTide Portfolio Exits

1 Portfolio Exit

SpringTide has 1 portfolio exit. Their latest portfolio exit was Pathology Watch on November 15, 2023.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

11/15/2023

Acquired

$99M

2

Date

11/15/2023

Exit

Acquired

Companies

Valuation

$99M

Acquirer

Sources

2

SpringTide Fund History

1 Fund History

SpringTide has 1 fund, including SpringTide Ventures Fund I LP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/23/2020

SpringTide Ventures Fund I LP

$14.78M

2

Closing Date

12/23/2020

Fund

SpringTide Ventures Fund I LP

Fund Type

Status

Amount

$14.78M

Sources

2

SpringTide Team

2 Team Members

SpringTide has 2 team members, including current Founder, Managing Partner, Austin C. Walters.

Name

Work History

Title

Status

Austin C. Walters

Founder, Managing Partner

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Austin C. Walters

Subscribe to see more

Work History

Title

Founder, Managing Partner

Subscribe to see more

Status

Current

Subscribe to see more

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.